Abstract:OBJECTIVE:This study was designed to investigate the possible synergism of atenolol and nitrendipine on blood pressure (BP) and blood pressure variability (BPV) reductions, baroreflex sensitivity (BRS) amelioration, and organ protection in hypertensive rats. METHOD:The dose was 20 mg/kg for atenolol, 10 mg/kg for nitrendipine and 20 + 10 mg/kg for the combination of these two drugs. In an acute study, a single dose was given via a catheter previously inserted into the stomach in spontaneously hypertensive rats (SHR). In a subacute study, SHR, deoxycorticosterone acetate (DOCA)-salt rats, and two-kidney, one-clip (2K1C) rats were used. They received the same dose by gavage daily for 10 days. BP was measured 24 h after drug administration. In chronic studies, these drugs at the aforementioned dose were mixed into rat chow. SHR were treated for 4 months. BP was then continuously recorded for 24 h. After the determination of BRS, rats were killed for organ-damage evaluation. RESULTS:In the acute study, it was found that the combination of atenolol and nitrendipine had an obviously greater and longer BP reduction than treatment with each of these two drugs separately. In the subacute study, an effective decrease in BP 24 h after administration was found only in the rats treated with the combination. In chronic studies, it was found that the combination possessed the obvious synergism on BP and BPV reduction, BRS amelioration and organ protection in SHR. Multiple-regression analysis showed that the decrease in left ventricular hypertrophy was most significantly related to the decrease in systolic BPV and BP, the decrease in aortic hypertrophy was most significantly related to the increase in BRS and the decrease in systolic BPV, and amelioration in the renal lesion was most significantly associated with the restoration of BRS. CONCLUSION:Treatment with a combination of atenolol and nitrendipine exhibited a rapid and persistent antihypertensive effect and possessed an obvious synergism on BP and BPV reduction, BRS restoration and organ protection in hypertensive rats. The decrease in BPV and the restoration of BRS may importantly contribute to organ protection in SHR with chronic treatment.

Synthesis and Antihypertensive Activity Evaluation in Spontaneously Hypertensive Rats of Nitrendipine Analogues

Prevention of myocardial fibrosis by using nitrendipine to the spontaneously hypertensive rats

Suppressive effect of nifedipine on production of inositol phosphates of vascular smooth muscle cells from spontaneously hypertensive rat (SHR)

Synthesis and Antihypertensive Activity Evaluation in Spontaneously Hypertensive Rats of Lacidipine Analogues

Synthesis and anti-hypertensive activity of C-4 substituted NO-donating benzopyran derivatives

Study on NO-donating antihypertensive agents I. Synthesis and antihypertensive activity of C-3 nitrate or furoxan substituted benzopyrans

Novel Nitric Oxide-Releasing Isochroman-4-one Derivatives: Synthesis and Evaluation of Antihypertensive Activity.

Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats.

Synergism of Hydrochlorothiazide and Nitrendipine on Reduction of Blood Pressure and Blood Pressure Variability in Spontaneously Hypertensive Rats

Study on NO-Donating Antihypertensive AgentsI. Synthesis and Antihypertensive Activity of C-3 Nitrate or Furoxan Substituted Benzopyrans

Chemical Synthesis, Safety and Efficacy of Antihypertensive Candidate Drug 221s (2,9)

Design of Novel Thiazole Bearing Pyrazole Derivatives and Their Dual Activities as ACE Inhibitors and Calcium Channel Blockers in Cardiovascular Disease

Synthesis and Biological Evaluations of Novel Nitric Oxide-donating Derivatives of [1,2,4]triazol-5(4H)-one with N-phenylpyrrolyl-2-tetrazole Moiety as Anti-hypertension Candidates

Design, Synthesis and Pharmacological Evaluation of Novel NO-Releasing Benzimidazole Hybrids as Potential Antihypertensive Candidate.

Design, Synthesis and Biological Evaluation of Isochroman-4-one Hybrids Bearing Piperazine Moiety As Antihypertensive Agent Candidates

Synthesis and Biological Study of 3-Butyl-1-(2,6-dichlorophenyl)-1h-[1,2,4]triazol-5(4h)-one Derivatives As Anti-Hypertension Drugs

Pharmacokinetics of the Analogs at C3 and C5 of M-Nifedipine in Beagle Dogs

In Vivo Evaluation of Two Novel Controlled-Release Nitrendipine Formulations

Design, Synthesis and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors.

Synthesis of potent vasodilating agents: in silico and in vitro evaluation of 6-(4-substitutedphenyl)-3-pyridazinone derivatives as potential hydralazine analogues

The Experimental Study of Decrease Blood Pressure with MN9202